Neonatal Hypothyroidism (Congenital Hypothyroidism)

Neonatal hypothyroidism means a newborn's thyroid gland is not making enough thyroid hormone. When it is present from birth it is called congenital hypothyroidism. Thyroid hormone is essential for a baby's growth and brain development, so the condition needs to be found and treated quickly, usually with daily thyroid hormone replacement. Hospitals in the United States screen newborns for it with a heel-prick blood test shortly after birth because babies often show few or no signs at first.

Hypothyroidism in infants can also be temporary and caused by something outside the body. One recognized cause is exposure to large amounts of iodine. On March 30, 2022, the FDA recommended that newborns and children through 3 years old have thyroid monitoring within 3 weeks after receiving injections of iodine-containing contrast media, the dye used in some X-rays and CT scans. The FDA added a warning to the labeling of the entire class of these contrast agents, noting that babies born premature or with underlying conditions such as heart problems may be at higher risk, although the agency said the thyroid problems it found were uncommon.

In litigation, neonatal hypothyroidism can come up in medical malpractice and birth injury claims alleging that a positive screen was not followed up, that a hospital failed to monitor thyroid levels after contrast imaging, or that delayed treatment caused developmental harm. These cases depend heavily on the medical timeline and expert review.

If your child had a delayed diagnosis, request the newborn screening results and all imaging records. See the birth injury and hypothyroidism entries, and how to sue a company.